Back to Trials
NCT06787066EARLY_PHASE1RecruitingAccepts Healthy Volunteers

Sympathetic Vascular Transduction Across the Menopause Transition: Contributing Mechanisms

University of Missouri-Columbia

Start Date

7/10/2025

Completion Date

12/1/2026

Summary

The investigators aim to assess the interactions between the sympathetic nervous system and the vasculature in women across the menopause transition to better understand why aging women have a higher risk of cardiovascular disease.

Eligibility Criteria

Age Range: 18 years to 70 years

Inclusion Criteria: * Assigned female at birth * 18-70 years of age * Body mass index (BMI) \<30 kg/m2 Exclusion Criteria: * Assigned male at birth * Pregnancy, breastfeeding * Body mass index ≥30 kg/m2 * Oral hormonal contraception in last 6 months, history of hormone replacement therapy, oophorectomy * Current smoking/nicotine use * Increased risk of bleeding, pro-coagulant disorders, clotting disorders, anticoagulation therapy * Nerve/neurologic disease * Cardiovascular, hepatic, renal, respiratory disease * Blood pressure ≥140/90 mmHg * Diabetes, Polycystic ovarian syndrome * Communication barriers * Prescription medications

Interventions

DRUG

Propranolol Hydrochloride

DRUG

Phentolamine Injection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Menopause

Locations

University of Missouri

Columbia, Missouri 65211

United States